Efficacy of Cetuximab in Combination with FOLFIRI in a Patient with KRAS Wild-Type Metastatic Anal Cancer (Q42322705)

26 October 2017

0 references

Efficacy of Cetuximab in Combination with FOLFIRI in a Patient with KRAS Wild-Type Metastatic Anal Cancer (English)

1 reference

26 October 2017

1 reference

1 reference

Hanna Barmettler

1

1 reference

26 October 2017

Paul Komminoth

series ordinal

2

1 reference

26 October 2017

Mathias Schmid

series ordinal

3

1 reference

26 October 2017

Donat Duerr

series ordinal

4

1 reference

26 October 2017

1 May 2012

1 reference

26 October 2017

Case reports in oncology

1 reference

26 October 2017

5

1 reference

26 October 2017

2

1 reference

26 October 2017

428-433

1 reference

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432997

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432997

Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432997

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432997

Combined multimodal approach to the treatment of metastatic anal carcinoma: report of a case and review of the literature

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432997

Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432997

Isolated chemotherapeutic perfusion of the pelvis for advanced rectal cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432997

Cetuximab-based treatment of metastatic anal cancer: correlation of response with KRAS mutational status.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432997

K-ras status in squamous cell anal carcinoma (SCC): it's time for target-oriented treatment?

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432997

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432997

Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal

17 August 2018

1 reference

12 December 2020

[5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer]

1 reference

12 December 2020

Cisplatin and 5-fluorouracil as salvage therapy for recurrent metastatic squamous cell carcinoma of the anal canal

1 reference

12 December 2020

Metastatic anal cancer: the search for cure

1 reference

12 December 2020

Identifiers

DOI

10.1159/000341371

1 reference

26 October 2017

1 reference

26 October 2017

PubMed publication ID

22949905

1 reference